Screening for testicular cancer (Review)

Dragan Ilic, Marie Misso

Research output: Contribution to journalArticleResearchpeer-review

29 Citations (Scopus)


Testicular cancer commonly affects men aged between 20 and 35 years. Screening for testicular cancer may reduce both morbidity and mortality, yet the effectiveness of any method is unknown. Equally, screening may also promote treatment procedures that are unwarranted or may adversely affect the health outcomes of the patient with no net benefit. Additionally, many organisations recommend against screening for testicular cancer due to the low incidence of testicular cancer and favourable outcomes in the absence of screening.
Original languageEnglish
Article numberCD007853
Pages (from-to)1 - 10
Number of pages10
JournalCochrane Database of Systematic Reviews
Publication statusPublished - 2011

Cite this